10 Stocks That Could 10X Over the Next 10 Years

Page 4 of 4

6. CRISPR Therapeutics AG (NASDAQ:CRSP)

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its price target for CRISPR Therapeutics AG (NASDAQ:CRSP) to $110 from $105 on March 17, retaining an Overweight rating in response to the company’s convertible note issuance. CRISPR Therapeutics AG (NASDAQ:CRSP) raised $600 million in convertible notes due in March 2031, convertible at $76.56 per share and with an effective interest rate of 1.73%. The company also allowed initial purchasers to pick up an extra $50 million in notes, with the transaction set to finalize in March of this year.

Moreover, CRISPR Therapeutics AG (NASDAQ:CRSP) plans to disclose Phase I data on zugo-cel in autoimmune diseases and B-cell lymphoma in the latter half of 2026. The company also plans to begin Phase I research on CTX340 in the first half of 2026 and CTX460 in mid-2026.

Meanwhile, in the second half of 2026, CRISPR Therapeutics AG (NASDAQ:CRSP) will provide Phase Ib data on CTX310 and proof-of-concept Phase II data on CTX611 in patients undergoing total knee replacement.

CRISPR Therapeutics AG (NASDAQ:CRSP) is a leader in gene-editing technology, using its proprietary gene sequencing platform to develop precise treatments for diseases requiring DNA modification.

While we acknowledge the potential of CRSP to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CSRP and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Stocks That Could 10X Over the Next 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.

Page 4 of 4